BIOMAT Database Logo BIOMAT Database Logo

Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992. 2000

B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden. borje.ridell@path.gu.se

An estimation of the incidence of polycythaemia vera (PV), essential thrombocythaemia (ET) and chronic idiopathic myelofibrosis (CIM) in the city of Göteborg, Sweden during the period 1983-1992 was made from a retrospective case analysis of patients registered as chronic myeloproliferative disorders (CMPD) at the Departments of Medicine and the Department of Pathology of the two major hospitals in the city. A total of 125 cases of PV, 56 males and 69 females were identified. The number of cases as well as the age-specific incidence increased with age. The over all annual gender-specific incidence was 2.69 cases per 10(5) male inhabitants and 3.12 cases per 10(5) female inhabitants. The incidence of PV in relation to the European Standard Population was 2.02 cases per 10(5) inhabitants and year. There were 72 cases, 20 males and 52 females, with ET. The age-specific incidence was in all ages higher for females than for males and increased with age. The annual gender-specific incidence was 0.96 per 10(5) male inhabitants and 2.35 per 10(5) female inhabitants. The incidence of ET in relation to the European Standard Population was 1.28 per 10(5) persons and year. There were 20 cases of CIM, 11 males and 9 females. The annual gender-specific incidence of CIM was 0.53/10(5) male inhabitants and 0.41/10(5) female inhabitants. The incidence of CIM in relation to the European Standard Population was 0.31 per 10(5) persons and year. Seven persons, 2 males and 5 females, had a CMPD that could not be included in any of the above-mentioned groups, but were registered as CMPD, unclassified.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008962 Models, Theoretical Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Experimental Model,Experimental Models,Mathematical Model,Model, Experimental,Models (Theoretical),Models, Experimental,Models, Theoretic,Theoretical Study,Mathematical Models,Model (Theoretical),Model, Mathematical,Model, Theoretical,Models, Mathematical,Studies, Theoretical,Study, Theoretical,Theoretical Model,Theoretical Models,Theoretical Studies
D009196 Myeloproliferative Disorders Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE. Disorder, Myeloproliferative,Disorders, Myeloproliferative,Myeloproliferative Disorder
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females

Related Publications

B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.
August 2004, Journal of internal medicine,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
[Incidence of cerebral palsy in Himeji City 1983-1992].
November 1998, No to hattatsu = Brain and development,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Epidemiology of hip fractures in Göteborg, Sweden, 1940-1983.
December 1984, Clinical orthopaedics and related research,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Myeloproliferative disorders in Sweden: Incidence trends and multiple tumors.
March 2009, Leukemia research,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Registration of myocardial infarction in the city of Göteborg, Sweden.
March 1975, Journal of chronic diseases,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.
November 2006, Journal of the National Medical Association,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.
February 2004, Haematologica,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
Stroke registration in Göteborg, Sweden, 1970-75. Incidence and fatality rates.
January 1979, Acta medica Scandinavica,
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
The HIV/AIDS grants economy in New York City, 1983-1992.
January 1996, Health affairs (Project Hope),
B Ridell, and J Carneskog, and H Wedel, and L Vilén, and I Høgh Dufva, and U H Mellqvist, and N Brywe, and H Wadenvik, and J Kutti
The accident service in Göteborg, Sweden.
August 1972, Injury,
Copied contents to your clipboard!